Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development Read more about Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development
Minnie Baylor-Henry Member of the Science & Technology CommitteeMember of the Nominating & Corporate Governance Committee Minnie Baylor-Henry Director
Lantheus Holdings to Present at the Barclays Global Healthcare Conference Read more about Lantheus Holdings to Present at the Barclays Global Healthcare Conference
Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member Read more about Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member
Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results Read more about Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results
Lantheus Receives U.S. FDA Approval of New Manufacturing Facility Read more about Lantheus Receives U.S. FDA Approval of New Manufacturing Facility
Lantheus Announces Presentation Featuring PYLARIFY® (Piflufolastat F18) at the 2022 ASCO GU Meeting Read more about Lantheus Announces Presentation Featuring PYLARIFY® (Piflufolastat F18) at the 2022 ASCO GU Meeting
Lantheus Holdings to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on February 24, 2022 at 8:00 a.m. Eastern Time Read more about Lantheus Holdings to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on February 24, 2022 at 8:00 a.m. Eastern Time
Lantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Advance AI-Enabled Imaging Biomarkers in Prostate Cancer Read more about Lantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Advance AI-Enabled Imaging Biomarkers in Prostate Cancer
